DA Perwitasari, JAM Wessels… - Japanese Journal of …, 2011 - FPCR ... Next to the antiemetic treatment regimen, patient characteristics such as age, gender, history of motion sickness and history of alcohol drinking are known to influence antiemeticdrug efficacy. ... To date, the reasons of variability in antiemeticdrug response are largely unknown. ...
J Willegaignon, M Sapienza, C Ono… - Clinical Nuclear …, 2011 - journals.lww.com ... Doses of an antiacid production drug were administered to patients for at least 3 days, an antiemeticdrug also being indicated when the occasion arose following therapy, to control excessive secretion of gastric acid, nausea, and vomiting. ... Related articles - All 3 versions
J Zang, M Hou, HF Gou, M Qiu, J Wang… - Supportive Care in …, 2011 - Springer ... mild to moderate. There were no serious drug-related adverse events between the two antiemetic regimens. ... Megestrol acetate is not well known as an antiemeticdrug. The evidence of the drug's antiemetic properties became apparent with some randomized clinical trials. ... Related articles - All 3 versions
[HTML] from nih.govDA Perwitasari, H Gelderblom, J Atthobari… - International journal of …, 2011 - Springer ... studies on antie- metic drugs in oncology are known, the clinician's decision regarding antiemetic treatment are currently based on patient's risk factors and emetogenicity of chemotherapeutic drugs rather than on genetic variants affecting antiemeticdrug reponse. ... Cited by 1 - Related articles - All 5 versions
PE Scuderi… - Anesthesia & Analgesia, 2011 - IARS ... In this study, the stated hypothesis was that “rolapitant is more effective than placebo in reducing the incidence of postoperative vomiting.” Postoperative vomiting and/or retching is easier to quantify as an end point in an antiemeticdrug study because no subjective evaluation of ... Related articles - All 3 versions